ATPase Copper Transporting Alpha (ATP7A) Genotyping
The ATP7A (ATPase Copper Transporting Alpha) gene is located at Xq21.1 and codes for a protein that facilitates the transport of copper across cell membranes and is present in almost all tissues except the liver. The protein is present in the Golgi apparatus and supplies copper to copper-dependent enzymes. In conditions with excess copper the enzyme can translocate to the cell membrane and functions in copper efflux from cells. ATP7A mutations are associated with X-linked cutis laxa, Menkes disease and X-linked distal spinal muscular atrophy type 3.
Menkes disease is an X-linked recessive disease characterized by poor copper absorption in the gut and deficient copper levels for copper-dependent enzyme function. Menkes disease first presents in infancy with developmental retardation, hypotonia, and occasional seizures.
- As and aid in the diagnosis of Menkes disease
- As an aids in investigating neuropathies
- Helpful in the diagnosis of occipital horn syndrome (cutis laxa)
- Useful in screening neonates or family members at risk
Negative for mutations analysis (no mutations or pathogenic variants detected)
Whole blood, EDTA (Lavender-top tube).
Stability
- Ambient: 3-5 days
- Refrigerated: 7 days
- Frozen: Unstable
- Biomedicines. 2021 Apr 6;9(4):391. [PMID: 33917579]
- J Bioenerg Biomembr. 2002 Oct;34(5):363-71. [PMID: 12539963]
- Eur J Hum Genet. 2010 May;18(5):511-8. [PMID: 19888294]
- Erratum in: Continuum (Minneap Minn). 2021 Feb 1;27(1):289. [PMID: 33003000]
- Clin Genet. 2021 Jan;99(1):53-66. [PMID: 33058140]
- GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2022. [PMID: 20301586]